EEStor Corp gets price target raise at Paradigm Capital
The latest positive data from EEStor Corp (TSX:ESU) has Paradigm Capital analyst J. Marvin Wolff raising his price target on the stock.
On Monday, EEStor announced it had completed he fourth phase of testing of its composite modified barium titanate (CMBT)-based energy storage technology at an independent testing lab. The company said the results showed continued improvement over previous phases.
“We are extremely pleased with the results and advancements of the technology over the past year,” said CEO Ian Clifford. “By including MRA in this round of testing, we have complete confidence in the test results. This, alongside increased time constants and capacitance, should accelerate our discussions with potential capacitor partners who rely heavily on these leading testing organizations for validation. With the company’s high energy density work under way, the imperative to realize sustainable and scalable solutions in energy storage has never been greater. I am confident that EEStor will become a leader in electrical energy storage as we continue to develop technology that will help replace non-renewable fossil fuels and challenging electrolytic energy storage that has significant safety and scalability concerns.”
Wolff says the potential for EEStor’s technology is huge. The analyst says he is comfortable with the assumptions of EEStor consultant and author of the Paumanok Report, Dennis Zogbi, that he garnered from previous communications. This mutually agreed upon valuation model assumes that EEStor’s initial target market will be the $687-million (a 2014 estimate) aluminum electrolytic capacitor market and that EEstor should be able to penetrate a single vertical in this market to the $100M level in annual sales over 5–6 years, representing 10–12% of this vertical within six years. He believes that the technology should be able to enter three such verticals within the same time frame. Wolff believes these test are an important step in that journey.
“In our opinion, these test results are significant, and have been achieved slightly ahead of target (scheduled for December),” says the analyst. “The data further suggests that EEStor’s CBMT powder has the potential to be disruptive to the high-voltage capacitor market, as it can provide both physically smaller solutions at the same charge capacity and also applied to solutions at much higher voltages, and has the ability to be produced at lower costs. With these results, and the stronger balance sheet, we are reducing our discount rate to 15% from 20% and increasing our target EBITDA multiple range to 10–14x from 8– 12x.”
As a result of these changes, Wolff today raised his one-year price target on EEStor Corp from $0.40 to $0.65, while maintaining his “Buy” recommendation on the stock, implying a return of 72 per cent at the time of publication, including dividend.
At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.
Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.
Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]
Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]
Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]
View Comments
"give me a perfect insulator and I'll make a perfect battery"
problem patent?